Letters
New management of gonorrhoea
Impact of antibiotic resistance
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d3523 (Published 14 June 2011) Cite this as: BMJ 2011;342:d3523
- Rachel Sacks, specialty doctor in genitourinary medicine/HIV1,
- Linda Greene, consultant in genitourinary medicine/HIV1
- 1Jefferiss Wing, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London W2 1NY, UK
- rachel.sacks{at}imperial.nhs.uk
Changes have recently been made to the British Association of Sexual Health and HIV (BASHH) guidelines on the management of Neisseria gonorrhoeae.1 2 Analysis of the UK Gonococcal Resistance to Antimicrobials Programme data showed decreasing sensitivity to cephalosporins.3 The BASHH clinical effectiveness group therefore drafted guidelines advising ceftriaxone 500 mg intramuscularly as …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.